Irish Life Investment Managers’s BioMarin Pharmaceuticals BMRN Stock Holding History

Irish Life Investment Managers’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$671K	Buy	+12,018	New	+$749K	0.01%	599

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Irish Life Investment Managers's BMRN Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2013: 12,018 shares worth $671K. The stake represents 0.01% of the portfolio and ranks #599 among its holdings.

280 funds tracked by Wall St. Rank hold BMRN as of Q2 2013.

Irish Life Investment Managers held 12,018 shares of BioMarin Pharmaceuticals worth $671K as of Q2 2013.
BioMarin Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
BioMarin Pharmaceuticals made up 0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #599 holding.
280 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.